WHY NOT TRY –
May 31, 2023 – The $42 million being allocated for ibogaine research is coming from Kentucky’s Opioid Settlement Fund. This fund was developed following a 2022 nationwide agreement with major pharmaceutical distributors and marketers of opioids to distribute $26 billion to populations affected by opioid addiction. Kentucky was allocated $478 million from this agreement — 50% of which goes to local government, and 50 percent of which is to be received by “the Commonwealth.” Funds allocated to Kentucky increased to over $842 million earlier this year. The commonwealth’s portion is managed by the Kentucky Opioid Abatement Advisory Committee , the organization which announced that $42 million will be invested in ibogaine research.
